TickerFactsScreenerDevelopers

Minerva Neurosciences, Inc. (NERV) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2012: $200.3K2013: $1.82M2014: $18.55M2015: $14.28M2016: $82.98M2017: $26.05M2018: $50.23M2019: $21.41M2020: $25.36M2021: $60.76M2022: $36.09M2023: $40.91M2024: $21.36M2025: $82.30M$82.30M
2012Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$82.30M+285.3%
2024$21.36M-47.8%
2023$40.91M+13.4%
2022$36.09M-40.6%
2021$60.76M+139.6%
2020$25.36M+18.4%
2019$21.41M-57.4%
2018$50.23M+92.8%
2017$26.05M-68.6%
2016$82.98M+480.9%
2015$14.28M-23.0%
2014$18.55M+919.9%
2013$1.82M+807.7%
2012$200.3K—